search

While the COVID-19 pandemic has caused a sanitary crisis around the world, pharmaceutical companies are going full steam ahead to develop solutions for diagnosing, treating and eventually curing the disease. The FTD SARS-CoV-2 Assay test kit presented by Siemens Healthineers on 2 April 2020 uses the same workflow as the company’s other FTD Respiratory Disease kits. It can be run in laboratories simultaneously with FTD Respiratory Pathogens 21, a molecular syndromic testing panel that identifies 21 different upper respiratory pathogens.

“With this molecular diagnostic assay, we want to make a contribution to fight the current COVID-19 global pandemic by delivering fast and accurate SARS-CoV-2 testing,” said Sebastian Kronmueller, Head of Molecular Diagnostics at Siemens Healthineers. “The Siemens Healthineers assay is designed to help researchers positively identify the virus in less than three hours so that healthcare professionals can proceed as quickly as possible with the necessary next steps on their patients’ triage paths.”

Luxembourg specialist in infectious disease detection kits

The test kit has been developed by Fast Track Diagnostics, a Siemens Healthineers Company located in Esch-sur-Alzette in the south of Luxembourg. Founded in 2007 as a spin-off of one of Luxembourg’s largest medical laboratories, Laboratoires Réunis, the company was acquired by Siemens Healthineers at the end of 2017.

Fast Track Diagnostics specialises in the design, development and manufacture of infectious disease detection kits that use syndromic multiplex real time PCR. FTD assays are validated on clinical samples and detect a comprehensive range of viruses, bacteria, fungi and parasites. They are in routine daily use in over 60 countries worldwide.

Pursuing emergency use approvals

The COVID-19 test kits are already being shipped within the European Union to be used for research only. The company is applying for Emergency Use Assessment and Listing from the World Health Organisation (WHO) for clinical use, as well as for Emergency Use Authorisation by the US Food and Drug Administration (FDA). At the same time, Siemens Healthineers is expanding its production capacity.

Read more

Luxembourg’s Circular by Design Challenge to go international

07-05-2021

The first edition of the Circular by Design Challenge came to an end on 29 April 2021, when the winners were announced by Minister of the Economy Franz Fayot. Its next edition, to be launched in autumn 2021, will be open to international creatives and partner companies.
Read more

Luxembourg passport ranks 4th in global mobility rating

07-05-2021

The Luxembourg passport is placed 4th in the Henley Passport Index, which analyses the number of destinations passport holders can access without the need for a visa.
Read more

EuroHPC headquarters inaugurated in Luxembourg

05-05-2021

Luxembourg hosts the European High Performance Computing Joint Undertaking (EuroHPC JU), a joint initiative of the EU, European countries and private partners with the mission of developing a world-class supercomputing ecosystem in Europe. Its headquarters was officially inaugurated on 3 May 2021.
Read more

Luxembourg’s Product Circularity Data Sheets on the way to becoming an international standard

04-05-2021

Luxembourg is at the forefront of developing data-related standards that will drive the clean technologies of the future. ISO has just decided to make Luxembourg’s Product Circularity Data Sheet (PCDS) initiative a future ISO / NP 59040 standard – a major step forward towards becoming an internationally recognised standard.
Read more

Architecture and art in Kirchberg

03-05-2021

Are you interested in art and architecture? Take a stroll through Luxembourg's business district Kirchberg or join a guided tour to discover modern works of art and contemporary buildings.
Read more

Resources all news

Fermer